Evidence map›Paper›PMID 21189253›Full record

ArticleThe Journal of biological chemistry2011

The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes.

Sandeep K Singh, Katarzyna M Wilczynska, Adrian Grzybowski, Jessie Yester, Bahiya Osrah, Lauren Bryan, Sarah Wright, Irene Griswold-Prenner, Tomasz Kordula

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nuclear factor one transcription factors: Divergent functions in developmental versus adult stem cell populations.Developmental dynamics : an official publication of the American Association of Anatomists · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Sandeep K SinghDepartment of Biochemistry, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
Katarzyna M Wilczynska
Adrian Grzybowski
Jessie Yester
Bahiya Osrah
Lauren Bryan
Sarah Wright
Irene Griswold-Prenner
Tomasz Kordula
Virginia Commonwealth University · US

Funding

Astrocyte-specific expression of serpin genesR01NS044118 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI KORDULA, TOMASZ K · 2004 to 2007
$762k
The role of sphingosine kinase 1 (SphK1) in primary glioblastomasR21NS063283 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI KORDULA, TOMASZ K · 2008 to 2009
$359k
The Role of Sphingosine Kinases in the Growth and Invasion of Giloma CellsF31NS060433 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRYAN, LAUREN E. · 2008 to 2009
$36k
NINDS NIH HHS F31NS060433NINDS NIH HHS R01 NS044118NINDS NIH HHS R01NS044118NINDS NIH HHS R21 NS063283NINDS NIH HHS R21NS063283
6 · The paper itself

Abstract

Transcription factors of the nuclear factor 1 (NFI) family regulate normal brain development in vertebrates. However, multiple splice variants of four NFI isoforms exist, and their biological functions have yet to be elucidated. Here, we cloned and analyzed human NFI-X3, a novel splice variant of the nfix gene, which contains a unique transcriptional activation (TA) domain completely conserved in primates. In contrast to previously cloned NFI-X1, overexpression of NFI-X3 potently activates NFI reporters, including glial fibrillary acidic protein (GFAP) reporter, in astrocytes and glioma cells. The GAL4 fusion protein containing the TA domain of NFI-X3 strongly activates the GAL4 reporter, whereas the TA domain of NFI-X1 is ineffective. The expression of NFI-X3 is dramatically up-regulated during the differentiation of neural progenitors to astrocytes and precedes the expression of astrocyte markers, such as GFAP and SPARCL1 (Secreted Protein, Acidic and Rich in Cysteines-like 1). Overexpression of NFI-X3 dramatically up-regulates GFAP and SPARCL1 expression in glioma cells, whereas the knockdown of NFI-X3 diminishes the expression of both GFAP and SPARCL1 in astrocytes. Although activation of astrocyte-specific genes involves DNA demethylation and subsequent increase of histone acetylation, NFI-X3 activates GFAP expression, in part, by inducing alterations in the nucleosome architecture that lead to the increased recruitment of RNA polymerase II.

Indexed as

Alternative SplicingAmino Acid SequenceAnimalsAstrocytesCalcium-Binding ProteinsCell DifferentiationCell Line, TumorConserved SequenceEmbryonic Stem CellsExtracellular Matrix ProteinsFibroblastsGenetic MarkersGlial Fibrillary Acidic ProteinGlioblastomaHEK293 CellsHumansCalcium-Binding ProteinsExtracellular Matrix ProteinsGenetic MarkersGlial Fibrillary Acidic ProteinNFI Transcription FactorsRNA Polymerase IISPARCL1 protein, human

Identifiers

PMID21189253
PMCPMC3044988
OpenAlexW2010879652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.